relebactam

The Week Ahead In Biotech: Johnson & Johnson Kickstarts Big Pharma Earnings
Yahoo/Benzinga
Sun, 07/14/19 - 04:09 pm
Merck
relebactam
TapImmune
earnings
JNJ
Seattle Genetics
Abbott Labs
Intuitive Surgical
Mirum Pharmaceuticals
Fulcrum Therapeutics
Genmab
FDA Action Alert: Karyopharm, Merck and Celgene
BioSpace
Mon, 07/1/19 - 10:54 pm
FDA
Karyopharm
Selinexor
Merck
relebactam
Celgene
Otezla
Merck’s Relebactam Met Primary Endpoints in Phase 3 Study
Market Realist
Mon, 04/23/18 - 09:18 am
Merck
relebactam
beta-lactamase inhibitors
clinical trials